Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.
Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
Vitamin D levels in Hispanics with multiple sclerosis.
Effect of autoimmune diseases on risk and survival in female cancers.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Audit on intravenous immunoglobulin (ivig) use in aberdeen royal infirmary neurology department according to 2005 association of british neurologists (abn) guidelines.
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures.
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
Imaging of glutamate in the spinal cord using GluCEST.
Autophagy and autoimmunity crosstalks.
Immune Therapy of Multiple Sclerosis - Future Strategies.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
Diagnosis and classification of autoimmune optic neuropathy.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Social disruption alters pain and cognition in an animal model of multiple sclerosis.
Italian validation of the 12-item multiple sclerosis walking scale.
Longitudinal changes in self-reported walking ability in multiple sclerosis.
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
The structure and function of the S1P1 receptor.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »